Abstract
Ribonuclease-H (RNase-H) enzyme of the human immunodeficiency virus (HIV) reverse transcriptase (RT) shows inhibitory activity with novel galloyl derivatives having enzymatic assays of IC50 S at sub to low micromolar concentration. The computational analysis of these stated galloyl derivatives was carried out in order to extract information and performance with the target proteins. The compounds N-hydroxylisoquinolinediones (HID), β-thujaplicinol, diketoacid, diketoacid ester, pyrimidinol carboxylic acids, naphthyridinones, 3hydroxypyrimidine-2,4-dione (HPD), and hydroxypyridonecarboxylic acids are the selected galloyl derivatives of human immunodeficiency virus-I (HIV-I) RNase-H active site inhibitors that were optimized using Turbomole software. Further evaluation of their NMR shielding of the stated compounds was performed using B3-LYP hybrid functional, and the def-SV basis set was carried out from the same software. These optimized compounds were then docked to targets (PDB Id: 5EGA and 3K2P) using AutoDock 4 software. After analyzing the docking result, Hydroxylisoquinoline and Naphthyridinones give better binding results with both the targets.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.